Ceftriaxone Sodium Injectable Supply

The Defense Logistics Agency, under the Department of Defense, has issued a subcontract for the supply of FDA-approved Ceftriaxone sodium injectable medication in specific NDC configurations designated for federal distribution. This procurement is classified under NAICS code 325412, which pertains to pharmaceutical and medicine manufacturing, indicating the commercial production and packaging of the drug in compliance with federal regulatory standards. The contract was posted on August 5, 2026, and is intended to support the federal supply chain with sterile injectable formulations meeting strict quality and safety requirements. The place of performance and delivery details are not specified in the provided data, but the medication will be distributed through federal channels, likely to meet the needs of military medical facilities, veterans' healthcare systems, or other authorized government entities. The contract does not indicate a set-aside status or specific small business designation. The official record and award details are accessible via the DIBBS portal, and the subcontractor is expected to ensure continuous supply, compliance with FDA regulations, and adherence to all federal procurement protocols for pharmaceuticals.